Translational Drug Development (TD2)
Business Services · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
13208 E Shea Blvd Ste 100, Scottsdale, A...Phone Number
(602) 358-8300Website
www.td2inc.comRevenue
<$5 MillionIndustry
About Translational Drug Development (TD2)
TD2 Oncology is a leading oncology contract research organization (CRO) that specializes in advancing oncology research by guiding new therapies from preclinical stages through clinical trials to FDA approval. The company offers a comprehensive suite of services including clinical trial design, regulatory support, and advanced flow cytometry, catering to biotech and pharmaceutical companies. With a focus on innovative cancer therapies, TD2 utilizes over 400 cancer models and a collaborative approach to ensure successful outcomes. Their mission is to accelerate the development of cancer treatments through strategic partnerships and a highly specialized team.Explore more
Translational Drug Development (TD2) Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Translational Drug Development (TD2)
Compare insights from companies similar to Translational Drug Development (TD2), focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Translational Drug Development (TD2) Tech Stack
A closer look at the technologies used by Translational Drug Development (TD2)
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Translational Drug Development (TD2)
Sign Up For FreeTo access detailed company insights
TD2 Oncology is a leading oncology contract research organization (CRO) that specializes in advancing oncology research by guiding new therapies from preclinical stages through clinical trials to FDA approval. The company offers a comprehensive suite of services including clinical trial design, regulatory support, and advanced flow cytometry, cater... Read More
